Suxibuzone is used for joint and muscular pain. Suxibuzone is an analgesic, It is a prodrug of the nonsteroidal anti-inflammatory drug phenylbutazone. Reference standards of Suxibuzone API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Suxibuzone (S2400000) [catalogue_number] => PA EPS2400000 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => suxibuzone-s2400000-paeps2400000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPS2400000
CAS :
Molecular Formula : NA
Molecular Weight : NA
stdClass Object ( [pname] => Suxibuzone impurity B (S2400004) [catalogue_number] => PA EPS2400004 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => suxibuzone-impurity-b-s2400004-paeps2400004 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPS2400004
stdClass Object ( [pname] => Suxibuzone impurity C (S2400006) [catalogue_number] => PA EPS2400006 [category_ids] => ,150, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => suxibuzone-impurity-c-s2400006-paeps2400006 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA EPS2400006
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
